Multiple Sclerosis Trial, Recruiting (NCT06827834)

Multiple Sclerosis Trial, Recruiting NCT06827834 Sponsor: Zuyderland Medisch Centrum Condition: Multiple Sclerosis

Printed from Voxsanity (voxsanity.com.au) — NCT06827834 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Multiple Sclerosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People aged between 18 and 65 years old
People who have been diagnosed with relapsing-remitting multiple sclerosis (MS), where their first MS episode occurred 5 years ago or less
People who have not yet started MS treatment, but are about to begin a disease-modifying therapy (a type of MS medication) that is currently approved in the Netherlands

Who may not be able to join:

People whose first MS episode happened more than five years ago
People who have already started taking MS disease-modifying treatment
People who are not able to give their own informed consent to take part in the study
People who are unable to have an MRI scan due to physical reasons, such as not fitting in a standard MRI scanner, or not being able to lie still for an extended period of time due to pain or breathing difficulties
People who are unable to have an MRI scan due to claustrophobia (fear of enclosed spaces)
People who have a medical reason that makes MRI scanning unsafe, such as having a pacemaker or metal fragments in the eye
People who are pregnant at the time of joining the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +31884597603

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06827834

Sponsor: Zuyderland Medisch Centrum

Phase: Not Applicable

Status: Recruiting

Condition: Multiple Sclerosis

Trial contact: +31884597603

More information: https://clinicaltrials.gov/study/NCT06827834

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People aged between 18 and 65 years old
People who have been diagnosed with relapsing-remitting multiple sclerosis (MS), where their first MS episode occurred 5 years ago or less
People who have not yet started MS treatment, but are about to begin a disease-modifying therapy (a type of MS medication) that is currently approved in the Netherlands

Who may not be able to join:

People whose first MS episode happened more than five years ago
People who have already started taking MS disease-modifying treatment
People who are not able to give their own informed consent to take part in the study
People who are unable to have an MRI scan due to physical reasons, such as not fitting in a standard MRI scanner, or not being able to lie still for an extended period of time due to pain or breathing difficulties
People who are unable to have an MRI scan due to claustrophobia (fear of enclosed spaces)
People who have a medical reason that makes MRI scanning unsafe, such as having a pacemaker or metal fragments in the eye
People who are pregnant at the time of joining the trial

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Zuyderland Medisch Centrum

Registry

ClinicalTrials.gov

Start date

6 August 2024

Est. completion

1 June 2028

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

Spinal cord lesion count

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov